Sponsor intelligence · OTHER
Clinical trials sponsored by
Ruijin Hospital.
Real, source-linked trial activity for Ruijin Hospital: 16 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Aug 5, 2026. Source-linked, daily-refreshed.
NA 4N/A 3PHASE2 2PHASE3 2PHASE1 2PHASE1/PHASE2 2EARLY_PHASE1 1
Newest Ruijin Hospital trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 2d ago | Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 7d ago | Learning Curve of SILS in CRC | N/A | COMPLETED | ↗ |
| 8d ago | Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 13d ago | Artificial Intelligence-Assisted Training for Novice Physicians in Ele | NA | NOT_YET_RECRUITING | ↗ |
| 13d ago | The Longitudinal Cohort of Cerebral Small Vessel Disease in Ruijin Hos | N/A | NOT_YET_RECRUITING | ↗ |
| 15d ago | A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 15d ago | The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteer | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 16d ago | AI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 21d ago | New Genotype-guided Treatment in Newly Diagnosed PTCL | Ph 1/Ph 2 | NOT_YET_RECRUITING | ↗ |
| 23d ago | Directional PSA Versus STN DBS for TD-PD | NA | RECRUITING | ↗ |
| 35d ago | An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therap | EARLY_Ph 1 | RECRUITING | ↗ |
| 38d ago | CD45RA-depleted DLI for the Prevention of Viral Infections in High-ris | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 42d ago | Electrical Impedance Tomography-Guided Identification of the Optimal L | NA | NOT_YET_RECRUITING | ↗ |
| 43d ago | Safety and Efficacy of Renal Denervation for Untreated Grade I Hyperte | NA | NOT_YET_RECRUITING | ↗ |
| 44d ago | CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral I | Ph 1/Ph 2 | RECRUITING | ↗ |
| 49d ago | A Multi-center, Prospective, Registry Study to Analyze the Clinical Ch | N/A | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Ruijin Hospital (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.